- Home
- CENT vs BLTE Comparison
CENT vs BLTE Comparison
Compare CENT & BLTE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CENT
- BLTE
- Stock Information
- Founded
- CENT 1955
- BLTE 2018
- Country
- CENT United States
- BLTE United States
- Employees
- CENT N/A
- BLTE N/A
- Industry
- CENT Consumer Specialties
- BLTE Biotechnology: Pharmaceutical Preparations
- Sector
- CENT Consumer Discretionary
- BLTE Health Care
- Exchange
- CENT Nasdaq
- BLTE Nasdaq
- Market Cap
- CENT 2.4B
- BLTE 2.1B
- IPO Year
- CENT N/A
- BLTE 2022
- Fundamental
- Price
- CENT $34.44
- BLTE $60.48
- Analyst Decision
- CENT Strong Buy
- BLTE Strong Buy
- Analyst Count
- CENT 2
- BLTE 4
- Target Price
- CENT $42.50
- BLTE $96.67
- AVG Volume (30 Days)
- CENT 78.9K
- BLTE 30.8K
- Earning Date
- CENT 08-06-2025
- BLTE 08-08-2025
- Dividend Yield
- CENT N/A
- BLTE N/A
- EPS Growth
- CENT N/A
- BLTE N/A
- EPS
- CENT 1.87
- BLTE N/A
- Revenue
- CENT $3,155,810,000.00
- BLTE N/A
- Revenue This Year
- CENT $0.42
- BLTE N/A
- Revenue Next Year
- CENT $1.77
- BLTE N/A
- P/E Ratio
- CENT $18.32
- BLTE N/A
- Revenue Growth
- CENT N/A
- BLTE N/A
- 52 Week Low
- CENT $31.97
- BLTE $43.70
- 52 Week High
- CENT $43.88
- BLTE $86.53
- Technical
- Relative Strength Index (RSI)
- CENT 42.44
- BLTE 46.26
- Support Level
- CENT $34.06
- BLTE $58.55
- Resistance Level
- CENT $34.78
- BLTE $62.49
- Average True Range (ATR)
- CENT 0.73
- BLTE 1.81
- MACD
- CENT -0.19
- BLTE -0.40
- Stochastic Oscillator
- CENT 13.87
- BLTE 26.19
About CENT Central Garden & Pet Company
Central Garden & Pet Co understands that home is central to life and has nurtured happy and healthy homes for over forty years. The segments of the company are the pet segment and garden segment. The company's trusted products are dedicated to helping lawns grow greener, gardens bloom bigger, pets live healthier and communities grow stronger. Central is home to a portfolio of more than sixty-five brands including Pennington, Nylabone, Kaytee, Amdro, and Aqueon, manufacturing and distribution capabilities, and a passionate, entrepreneurial growth culture. Central Garden and Pet is based in Walnut Creek, California, and has offices across North America and Europe.
About BLTE Belite Bio Inc
Belite Bio Inc is a clinical-stage biopharmaceutical drug development company focused on novel therapeutics targeting untreatable eye diseases involving retinal degeneration such as atrophic age-related macular degeneration and autosomal recessive Stargardt disease or STGD1, both of which progressively to permanent blindness, and metabolic diseases such as non-alcoholic fatty liver disease, or NAFLD, nonalcoholic steatohepatitis, or NASH, type 2 diabetes, or T2D, and gout.